SQSTM1 gene
The SQSTM1 gene provides instructions for making the sequestosome-1 protein, which plays a critical role in bone remodeling, cell recycling, and immune responses.
Normal Function
The SQSTM1 gene provides instructions for making a protein called sequestosome-1. This protein helps regulate bone remodeling, a normal process in which old bone is broken down and replaced by new bone. Sequestosome-1 is involved in a chemical signaling pathway that promotes the formation and activity of bone cells called osteoclasts, which are specialized cells that break down bone tissue during bone remodeling.
In addition to its role in bone remodeling, sequestosome-1 may have other functions, although these are less well-defined. Sequestosome-1 may be involved in recycling worn-out cell parts and unneeded proteins (autophagy), the self-destruction of cells when they are no longer needed (apoptosis), and the body's immune responses and inflammatory reactions.
Health Conditions Related to Genetic Changes
Paget disease of bone
Variants (also called mutations) in the SQSTM1 gene have been associated with Paget disease of bone. This disorder causes one or more bones to be larger than normal, misshapen, and easily broken (fractured). Many SQSTM1 gene variants lead to the substitution of one protein building block (amino acid) for another in sequestosome-1.
Through a mechanism that is not well understood, SQSTM1 gene variants lead to an increase (overactivation) in the chemical signaling pathway that promotes osteoclast formation. This increase in signaling stimulates the production of too many osteoclasts and triggers the breakdown of bone. In people with Paget disease of bone, affected bone is broken down by osteoclasts and replaced by bone cells called osteoblasts much faster than usual. As a result, the new bone tissue is less organized and weaker than normal bone. These problems with bone remodeling cause certain bones to become unusually large, misshapen, and prone to fracture.
Amyotrophic lateral sclerosis
MedlinePlus Genetics provides information about Amyotrophic lateral sclerosis.
Other disorders
- Frontotemporal dementia (FTD): Variants in the SQSTM1 gene can cause FTD, a progressive brain disorder that affects personality, behavior, and language. FTD is often considered to be part of the same disease spectrum as amyotrophic lateral sclerosis (ALS). These variants cause cells to produce a version of the sequestosome-1 protein that does not function properly, disrupting cellular processes such as autophagy and apoptosis.
- Distal myopathy with rimmed vacuoles (DMRV): Variants in the SQSTM1 gene have been found in a few individuals with this muscle disorder. Affected individuals have muscle weakness (myopathy) that typically begins in adulthood, primarily affecting the shoulders and distal muscles, such as those in the hands and feet.
- NADGP: This condition involves a decline in cognitive function (neurodegeneration), poor coordination and balance (ataxia), involuntary tensing of the muscles (dystonia), and difficulty following movements with the eyes (gaze palsy). The variants lead to impaired autophagy, resulting in the buildup of abnormal proteins in brain cells.
Other Names for This Gene
- A170
- autophagy receptor p62
- OSIL
- p60
- p62
- p62B
- PDB3
- ubiquitin-binding protein p62
- ZIP3
